A randomized trial shows no significant difference in the primary endpoint of quality of life at 6 months between treatment with digoxin vs the beta-blocker bisoprolol (Zebeta) in patients with atrial ...

Evaluation of the drug by Canadian regulatory authorities is under way. Paladin Labs will take over distribution of BTG’s treatment for digoxin toxicity or overdose in Canada. DigiFab™ is currently ...

Digoxin use among patients who are on hemodialysis (HD) may increase their risk of death, especially if they have low predialysis potassium levels, a study showed. HD patients who used digoxin had a ...

A trial by AIIMS shows digoxin may reduce worsening heart failure in rheumatic heart disease patients, offering a low-cost ...

Digoxin recalled over mislabeling Two lots of Digoxin were mislabeled, leading to a recall. Digoxin is used for the treatment of mild to moderate heart failure in children and adults. The Food and ...

When a 24-year-old woman took a dietary supplement called "raiz de tejocote," she encountered some dangerous and unpleasant side effects. On arrival to the emergency department, she was experiencing ...

Digoxin, a cardiac glycoside derived from the foxglove plant, has been a mainstay of treatment in systolic heart failure and in rate control for atrial fibrillation. By inhibiting the cardiac ...

BUFFALO, N.Y. – University at Buffalo researchers have identified for the first time an enzyme in the foxglove plant that is responsible for the production of compounds needed to make the heart ...